ArticleJID innovations : skin science from molecules to population health2026
SOX2 Is a Potential Diagnostic Biomarker and Anticancer Target in Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa: A Case Series Study.
Clara Harrs et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.